Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDand… (NCT04734041) | Clinical Trial Compass
CompletedNot Applicable
Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)
United States20 participantsStarted 2020-12-23
Plain-language summary
A feasibility study of an integrative medicine program among patients with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS)
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18-65
* Beighton score of 4 or more to confirm joint hypermobility diagnosis
* Baseline VAS Score of 1 or more
* Not currently, or already a patient of Dr. Schaefer and Healthy Living Community
* Ability to provide written informed consent
* Willingness to participate in 9-week integrative medicine intervention (and make dietary and lifestyle changes)
* Willingness to attend 1 in-person screening visit and 2 virtual office visits (or 3 virtual visits, if medical documentation of Beighton score can be provided in advance of enrollment, and all other criteria are met)
* Access to an electronic device for MyFitnessPal food-tracker use (i.e mobile device, tablet, laptop)
Exclusion Criteria:
* Pregnant and lactating women, or planned pregnancy over the next 3 months
* Consumption of more than 14 (men) or 7 (women) alcoholic drinks per week
* History of disordered eating or eating disorder
* Body mass index (BMI) considered underweight (\<18.5)
* Weight loss from metastatic cancer
* Unable to make dietary changes or participate in a 9-integrative medicine nutritional intervention
* Those with significant dietary changes, new medications, or new exercise routines within the past 90 days
* Currently, or already, a patient of Dr. Schaefer and Healthy Living Community